BioSpace News Archive

THINK Surgical, Inc., an innovator in the field of orthopedic active robot surgery, and Ortho Development Corporation, an orthopedic device design and manufacturing company, have announced FDA clearance to use Ortho Development’s Balanced Knee® System (BKS), and BKS TriMax® implants

MANA Therapeutics, a clinical-stage company creating nonengineered, off-the-shelf allogeneic cell therapies that target multiple cancer antigens, today announced the appointment of Arthur (Andy) Hurwitz, Ph.D., t

Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers, today announced that data from pre-clinical studies of its RAF inhibitor candidate,

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for respiratory diseases, cancer and other indications, today announced that it will host a first quarter 2021 investor call on Monday, May 17, 2021 at 8:00 AM EDT to discuss financial results and provide a corporate update.

Adverum Biotechnologies Inc. (“Adverum”) (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today issued the following statement regarding the Annual Meeting of Stockholders (“Annual Meeting”)

Halberd Corporation was recently discussed in Penny Stocks News and Wall Street Trader publications as a BREAKOUT stock to watch with a projected share price of HALB to rise above the $0.06/share level.